Elsevier

Human Pathology

Volume 25, Issue 4, April 1994, Pages 337-342
Human Pathology

Original contribution
Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel “paraffin”-reactive MIB1 antibody

https://doi.org/10.1016/0046-8177(94)90140-6Get rights and content

Abstract

Tumor proliferation is inversely associated with survival in patients with breast carcinoma. Although the proliferation marker Ki-67 antigen correlates with mitotic figure count (MFC) in breast carcinoma (number of mitotic figures per high-powered field), the more precise association of Ki-67 antigen expression with mitotic figure index (MFI) (number of mitotic figures per tumor cells) and histologic grade remains incompletely defined, especially when using the new “paraffin”-reactive monoclonal antibody MIB1 to mark the Ki-67 antigen. To determine the association of Ki-67 antigen expression with mitotic figure content we immunostained 50 formalin-fixed, paraffin-embedded breast carcinomas with the MIB1 monoclonal antibody and correlated the results with MFC, MFI, and Scarff-Bloom-Richardson grade. The Ki-67 antigen-labeling index (K67LI) was the number of MIB1-positive cells/1,000 tumor cells, the MFI was the number of mitotic figures/1,000 tumor cells, and the MFC was the number of mitotic figures/10 high-powered fields. The K67LI correlated highly with the MFI (r = .76, P < .0001), MFC (r = .78, P < .0001), and Scarff-Bloom-Richardson grade (r = .73, P < .0001). In addition, analysis of variance showed that MFI was more precise than MFC in estimating K67LI and thus a more repeatable measure of tumor proliferation. Moreover, measurements made by MFI were as precise as those made by K67LI. Therefore, the correlation of K67LI with mitotic figure content was strong enough to suggest that a very carefully measured MFI provides an estimate of tumor growth fraction equivalent to the K67LI. However, which method is optimal for estimating tumor proliferation rate remains unclear.

References (32)

  • WH Goodson et al.

    In vivo measurement of breast cancer growth rate

    Arch Surg

    (1991)
  • MD Linden et al.

    Clinical application of morphologic and immunocytochemical assessments of cell proliferation

    Am J Clin Pathol

    (1992)
  • JS Meyer et al.

    Reliability and stability of the thymidine labeling index of breast carcinoma

    Lab Invest

    (1986)
  • JS Meyer et al.

    Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling

    J Histochem Cytochem

    (1989)
  • DW Visscher et al.

    Clinical significance of pathologic, cytometric, and molecular parameters in carcinoma of the breast

    Adv Pathol Lab Med

    (1992)
  • DS Weinberg

    Proliferation indices in solid tumors

    Adv Pathol Lab Med

    (1992)
  • Cited by (0)

    View full text